Clinical Trials Logo

Filter by:
NCT ID: NCT05709990 Completed - Overactive Bladder Clinical Trials

Efficacy and Safety of High Dose Vitamin D Supplementation for Overactive Bladder Dry in Children

Start date: January 15, 2023
Phase: N/A
Study type: Interventional

This prospective, randomized, 3-arms, parallel-design, controlled clinical trial is conducted to determine whether high dose vitamin D supplementation (combined with standard urotherapy ) improves outcomes, compared with solifenacin (combined with standard urotherapy ) ,and standard urotherapy alone in children with OAB dry.

NCT ID: NCT05708664 Completed - Breast Cancer Clinical Trials

Precision Breast Conserving Surgery With Guidance.

Start date: August 1, 2021
Phase: N/A
Study type: Interventional

From 2021 to 2022, 31 patients with unifocal breast cancer were enrolled for precision breast conserving surgery (PBCS) guided by wire guided localization (WGL) combined with CT guided 3D reconstruction. Surrounded WGL was performed under local anesthesia, followed by an immediate contrast enhanced CT scan. PBCS guided by CT guided 3D reconstruction was performed one day after the localization. Women who underwent palpation guided breast conserving surgery (BCS) were included as control. Two-sided Student t test, Fisher's exact test and chi-square test was applied.

NCT ID: NCT05708144 Completed - Breast Cancer Clinical Trials

NIR Fluorescent Molecular Probe for the Identification of Breast Tissue

NIR
Start date: February 17, 2023
Phase: N/A
Study type: Interventional

Accurate evaluation of tumor boundaries in breast-conserving surgery is critical to reducing the second operation of patients. Near-infrared (NIR) fluorescence imaging using molecular agents has shown promise for in situ imaging during resection. However, very effective probes can be applied to clinical trials up to now, which limits the clinical application of fluorescence imaging. Here we developed a new technology that can quickly identify the tumor area of the resected breast tissue during the operation and distinguish the tumor boundary. In brief, the breast tissues were incubated with the probe immediately after intraoperative resection and imaged to identify the tumor area and distinguish the tumor boundary. The accuracy of fluorescence imaging was confirmed by pathological diagnosis.

NCT ID: NCT05707598 Completed - Colorectal Cancer Clinical Trials

Multivisceral Radical Resection for Surgical T4b Colorectal Cancer: Propensity Score-matched Study Comparing the the Laparoscopic and Open Approaches

C-PelvEx-01
Start date: January 1, 2023
Phase:
Study type: Observational

This study attempts to compare safety and long-term oncological outcomes between laparoscopic surgery and open surgery in the treatment of clinical T4b Colorectal cancer.

NCT ID: NCT05707533 Completed - Clinical trials for Pelvic Organ Prolapse

Vaginal Adventitia Reserved and Anatomical Implant Technique of Transvaginal Mesh Procedure for Pelvic Organ Prolapse

Start date: August 1, 2022
Phase:
Study type: Observational

After obtaining an institutional ethics approval (#2021833), the investigators retrospectively reviewed patients with Pelvic organ prolapse (POP) who underwent Transvaginal Mesh (TVM) in their hospital during June 2008 and December 2020. The goal of this observational study is to introduce the Vaginal Adventitia Reserved and Anatomical Implant Technique in Transvaginal mesh surgery, and to report long term efficacy and safety results of this technique. The main questions it aims to answer are: - How to reduce the potential risk of mesh-related complications when performing TVM? - How effective is the use of the Vaginal Adventitia Reserved and Anatomical Implant Technique when performing TVM? Participants will be asked to fill the Pelvic Floor Distress Inventory (PFDI-20) at final follow-up, and the Prosthesis/Graft Complication Classification Code was used to record the mesh-related complications.

NCT ID: NCT05706441 Completed - COVID-19 Clinical Trials

Lung and Diaphragm Ultrasound Evaluation During Weaning From Mechanical Ventilation in COVID-19 Patients

Start date: January 11, 2023
Phase:
Study type: Observational

The goal of this observational study is to learn about the function of lung and diaphragm ultrasound during weaning from mechanical ventilation in COVID-19 patients. The aim of this study was that the lung ultrasound score and diaphragm muscle mobility could be a potential predictive factor of weaning success.

NCT ID: NCT05706064 Completed - COVID-19 Clinical Trials

Survey of COVID-19 Infection

Start date: December 28, 2022
Phase:
Study type: Observational [Patient Registry]

Using online questionnaires, we will obtain data regarding COVID-19 infection and treatment, including incidence rate, hospitalization rate, severity of the infection, medications, mortality rate, etc, in both hospital and communities after the change of disease control policy in China.

NCT ID: NCT05703841 Completed - Healthy Clinical Trials

A Study of JNJ-77242113 Following Oral Administration in Healthy Chinese Adult Participants

Start date: February 14, 2023
Phase: Phase 1
Study type: Interventional

The purpose of the study is to assess what drug does to body when healthy Chinese participants receive single oral dose of JNJ-77242113.

NCT ID: NCT05703477 Completed - Clinical trials for Clostridium Difficile Infection

The Dynamic Fluctuation of Donor Microbiota Affects the Prognosis of Fecal Microbiota Transplantation for C. Difficile Infection

Start date: January 1, 2020
Phase: N/A
Study type: Interventional

Fecal microbiota transplantation (FMT) achieves the purpose of treating intestinal and extra-intestinal diseases by transplanting the functional microbes in the feces of healthy people into the patient's intestine through the upper or lower alimentary tract routes to rebuild the patient's intestinal microbiota. Recently, FMT has been widely used in the treatment of various gastrointestinal diseases, including but not limit in CDI. In this study, we focused on the demonstration of FMT action mechanism in CDI treatment.

NCT ID: NCT05701826 Completed - Clinical trials for Skeletal Muscle Relaxation

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HRS3797 in Healthy Subjects

Start date: February 15, 2023
Phase: Phase 1
Study type: Interventional

This is a single-center, open-label, dose-escalation study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of HRS3797 in Chinese adults. To evaluate the effect of IV infusion duration on the safety, tolerability, pharmacokinetics and pharmacodynamics of HRS3797. To explore the ED95 dosage of HRS3797 in Chinese adults.